Company profile for XtalPi

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. With tightly interwoven quantum physics, AI, and high-performance cloud computing algorithms, XtalPi’s ID4 platform provides accurate predictions on the physicochemical and pharmaceutical properties of small-molecule candidates...
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. With tightly interwoven quantum physics, AI, and high-performance cloud computing algorithms, XtalPi’s ID4 platform provides accurate predictions on the physicochemical and pharmaceutical properties of small-molecule candidates for drug design, solid-form selection, and other critical aspects of drug development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
245 Main St, 12th Floor, Cambridge MA 02142
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/lilly-expands-xtalpi-collaboration-345m-antibody-development-pact

FIERCE BIOTECH
06 Nov 2025

https://www.prnewswire.com/news-releases/xtalpi-ai-drug-discovery-collaboration-reaches-milestone-as-pharmaengines-novel-prmt5-inhibitor-pep08-receives-clinical-trial-approvals-302550869.html

PR NEWSWIRE
09 Sep 2025

https://www.prnewswire.com/news-releases/xtalpi-signs-mou-with-dong-a-st-for-joint-research-and-development-of-immunology-and-inflammation-therapies-302534023.html

PR NEWSWIRE
19 Aug 2025

https://www.prnewswire.com/news-releases/xtalpi-and-dovetree-announce-landmark-6-billion-ai-drug-discovery-collaboration-302523824.html

PR NEWSWIRE
07 Aug 2025

https://www.prnewswire.com/news-releases/xtalpi-and-pfizer-expand-strategic-collaboration-to-advance-ai-driven-drug-discovery-and-materials-science-simulations-302494033.html

PR NEWSWIRE
29 Jun 2025

https://www.businesswire.com/news/home/20241204853282/en

BUSINESSWIRE
04 Dec 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty